CRNX - Company ID 0001658247
The table below shows Crinetics Pharmaceuticals, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $114.34M | $110.90M | $53.73M | $94.57M | $317.27M | $302.16M |
| Short-term investments | $1.18B | $981.39M | $1.14B | $1.18B | $545.40M | $560.79M |
| Receivables | $5.68M | - | - | - | - | - |
| Inventory | $3.06M | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.32B |
| $1.12B |
| $1.22B |
| $1.29B |
| $877.59M |
| $874.78M |
| Property, plant & equipment | $13.50M | $14.38M | $14.67M | $12.63M | $11.71M | $12.25M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.40B | $1.20B | $1.29B | $1.36B | $937.37M | $935.53M |
| Accounts payable | $12.88M | $6.11M | $11.32M | $9.84M | $4.94M | $8.87M |
| Total current liabilities | $71.09M | $74.16M | $68.40M | $57.31M | $53.56M | $54.38M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $120.68M | $123.86M | $118.05M | $107.33M | $104.39M | $104.77M |
| Retained earnings | -$1.55B | -$1.29B | -$1.16B | -$1.05B | -$871.51M | -$794.69M |
| Total equity | $1.28B | $1.07B | $1.17B | $1.25B | $832.98M | $830.76M |